Bots Inc. (OTC: BTZI) is innovative technological company. Bots Inc. interests in FinTech, Blockchain, Cryptocurrency. 



1064 Ave Ponce De Leon, Suite 200, San Juan, PR

+1 (929) 205-8277

Press Releases

MCIG Signs Multi-Product Partnership Agreement With EmotekLabs, LLC

BEVERLY HILLS, CA–(Marketwired – Sep 10, 2015) –  mCig, Inc. (the “Company”)(OTCQB : MCIG ), a leading distributor of innovative products, technologies, and services for the global medical and legal recreational cannabis industry, announced today that the Company has signed a partnership agreement with EmotekLabs, LLC, a Colorado-based company that engineers multiple award-winning botanical commercial extractors. The partnership will allow mCig to exclusively market the Emotek Cannapod and the Emotek line of extractors.

States like Colorado are starting to require extraction facilities to be in clean rooms. The modular Cannapod is a simple solution for indoor and outdoor facilities, fully complying with the requirements and giving mCig another product in its grower services division.

The partnership also will focus on development, marketing, and distribution of an exclusive line of “High Quality” CBD & THC Oils and ancillary products.

“We are excited about the opportunity to work with Emotek and distribute their product to all legal zones around the world,” said Paul Rosenberg, CEO of mCig, Inc. “The Emotek product line is a welcome addition to the portfolio of products mCig can offer.”

“Our decision to partner with mCig’s Master Distributor sales approach allows us to focus on the ever evolving needs of our industry,” said Jason Emo, the owner of EmotekLabs LLC.

About EmotekLabs, LLC.

EmotekLabs started with a vision to create a safer way to extract cannabis oils. EmotekLabs designs, develops, and manufactures the world’s safest and most efficient award winning “certified” botanical extractor on the market. The company is at the forefront of cannabis and hemp extraction and a pioneer and inventor of the Live Resin™ Cannabis extraction process. The company is constantly innovating and setting the standards for the industry and our equipment is “certified” by The American Society of Mechanical Engineers (ASME), the American Society for Nondestructive Testing (ASNT), and the National Fire Protection Association (NFPA). Emotek extractors are engineered and hand-built in America to withstand the extremes needed for commercial extraction. Emotek extractors have won more awards than any other extractor on the market, including over two dozen High Times Cannabis concentrates awards!

About mCig, Inc.

mCig, Inc. ( OTCQB : MCIG ) is committed to being the leading distributor of technology, products, and services for the global medical and legal recreational cannabis industry. The Company’s Master Distributor sales approach allows mCig to partner with or acquire best-of-breed companies to serve as exclusive sales representatives, distributing their products through mCig’s multiple channels and sub-distributors throughout the United States, Europe, United Kingdom, and Asia. mCig focuses sales efforts on growers, consumers and dispensaries, and provides a complete line of products, technology, and services, including turnkey growing environments; security services; software and information technology; consulting services; financing and more. mCig maintains its roots by offering top selling CBD Vape lines and CBD products. The company is headquartered in Beverly Hills, California. Follow mCig, Inc. on Twitter at @mCigs.

Safe Harbor Statement

Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Any forward-looking statements contained herein are based on current expectations, but are subject to a number of risks and uncertainties. The factors that could cause actual future results to differ materially from current expectations include, but are not limited to, risks and uncertainties relating to the Company’s ability to develop, market and sell products based on its technology; the expected benefits and efficacy of the Company’s products and technology; the availability of substantial additional funding for the Company to continue its operations and to conduct research and development, and future product commercialization; and the Company’s business, research, product development, regulatory approval, marketing and distribution plans and strategies.